Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Cash from Investing Activities (2016 - 2025)

Dexcom (DXCM) has disclosed Cash from Investing Activities for 16 consecutive years, with $306.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 200.95% to $306.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $536.0 million through Dec 2025, up 358.31% year-over-year, with the annual reading at $536.0 million for FY2025, 358.31% up from the prior year.
  • Cash from Investing Activities for Q4 2025 was $306.6 million at Dexcom, up from $192.8 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $414.9 million in Q4 2023, with the low at -$555.9 million in Q2 2023.
  • Average Cash from Investing Activities over 5 years is -$45.8 million, with a median of -$87.9 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities crashed 1967.08% in 2021, then soared 690.69% in 2022.
  • Over 5 years, Cash from Investing Activities stood at -$496.1 million in 2021, then skyrocketed by 60.87% to -$194.1 million in 2022, then skyrocketed by 313.76% to $414.9 million in 2023, then plummeted by 173.2% to -$303.7 million in 2024, then soared by 200.95% to $306.6 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $306.6 million, $192.8 million, and -$63.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.